Medical Properties (MPW) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates

Wall Street analysts expect Medical Properties (MPW) to post quarterly earnings of $0.28 per share in its upcoming report, which indicates a year-over-year decline of 34.9%. Revenues are expected to be $235.38 million, down 38.1% from the year-ago quarter.

Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted downward by 16.7% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.

Prior to a company's earnings announcement, it is crucial to consider revisions to earnings estimates. This serves as a significant indicator for predicting potential investor actions regarding the stock. Empirical research has consistently demonstrated a robust correlation between trends in earnings estimate revision and the short-term price performance of a stock.

While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.

Bearing this in mind, let's now explore the average estimates of specific Medical Properties metrics that are commonly monitored and projected by Wall Street analysts.

Analysts' assessment points toward 'Revenues- Interest and other income' reaching $26.31 million. The estimate points to a change of -36.9% from the year-ago quarter.

The average prediction of analysts places 'Revenues- Income from financing leases' at $18.76 million. The estimate points to a change of -61.7% from the year-ago quarter.

The collective assessment of analysts points to an estimated 'Revenues- Rent billed' of $187.14 million. The estimate suggests a change of -19.3% year over year.

Analysts predict that the 'Revenues- Straight-line rent' will reach -$63.78 million. The estimate points to a change of -209.9% from the year-ago quarter.

Based on the collective assessment of analysts, 'Real estate depreciation and amortization' should arrive at $163.28 million. The estimate is in contrast to the year-ago figure of $81.45 million.

View all Key Company Metrics for Medical Properties here>>>

Medical Properties shares have witnessed a change of +20.9% in the past month, in contrast to the Zacks S&P 500 composite's +4.6% move. With a Zacks Rank #4 (Sell), MPW is expected underperform the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s credited with a “watershed medical breakthrough” and is developing a bustling pipeline of other projects that could make a world of difference for patients suffering from diseases involving the liver, lungs, and blood. This is a timely investment that you can catch while it emerges from its bear market lows.

It could rival or surpass other recent Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Medical Properties Trust, Inc. (MPW) : Free Stock Analysis Report

To read this article on click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.